Accuray Inc. Stock
Price
Target price
€1.64
€1.64
-1.200%
-0.02
-1.200%
€7.76
07.05.24 / Tradegate
WKN: A0MKWM / Symbol: ARAY / Name: Accuray / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Accuray Inc. Stock
We can see a decrease in the price for Accuray Inc.. Compared to yesterday it has lost -€0.020 (-1.200%).
Currently there is a rather positive sentiment for Accuray Inc. with 3 Buy predictions and 0 Sell predictions.
With a target price of 7 € there is potential for a 326.83% increase which would mean more than doubling the current price of 1.64 € for Accuray Inc..
Pros and Cons of Accuray Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
S********** s********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Accuray Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Accuray Inc. | -1.200% | 13.889% | -23.364% | -49.693% | -37.879% | -56.614% | - |
MicroVision Inc | -23.770% | -24.356% | -25.239% | -51.526% | -55.336% | -89.773% | 44.430% |
Fonar Corp. New | -1.850% | 5.298% | -2.454% | 3.922% | -10.169% | 12.766% | -11.892% |
Allscripts Healthcare | -1.370% | -1.370% | -2.703% | -32.075% | -22.162% | -45.038% | -18.901% |
Comments
Accuray Incorporated (NASDAQ: ARAY) had its "buy" rating re-affirmed by analysts at Roth Capital.
Show more
Ratings data for ARAY provided by MarketBeat
Accuray Incorporated (NASDAQ: ARAY) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $9.00 price target on the stock.
Show more
Ratings data for ARAY provided by MarketBeat
Accuray Incorporated (NASDAQ: ARAY) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $7.50 price target on the stock.
Show more
Ratings data for ARAY provided by MarketBeat